Latka logo

Altris AI Revenue (2025)

Altris AI generated an estimated $2.6M in annual revenue in 2025. Source: GetLatka estimate

Altris AI is web platform for automated OCT scan analysis with the help of artificial intelligence. It's the system that detects more than 70+ retina pathologies on OCT scans, including rare pathologies. It is also capable of differentiating between pathological and non-pathological b-scans.

Altris AI speeds up the process of OCT examination and makes this diagnostic method more accurate.

The system is fully GDPR compliant, data is encrypted and can’t be reached by any 3rd party. We have a CE certificate and FDA clearance is in the process. Altris AI is used in 30 + eye clinics and optometry centers in the world.

Last updated

Altris AI Revenue

Altris AI generated an estimated $2.6M in annual revenue in 2025.

Altris AI Revenue GrowthReported revenue / ARR over time · latest figure estimated$0$600K$1.2M$1.8M$2.4M$3M2025$2.6MSource: GetLatka.com
YearMilestoneSource
2025Altris AI Hit $2.6m revenue in September 2025Estimated

Founder / CEO

We don't have Altris AI's Founder / CEO on record yet.

Altris AI Employees & Team Size

Altris AI employs approximately 24 people as of 2025.

Altris AI Team GrowthReported headcount over time061218243020252424Source: GetLatka.com
YearMilestoneSource
2025Reached 24 employees (September 2025)LinkedIn

Frequently Asked Questions about Altris AI

What is Altris AI's revenue?

As of 2025, Altris AI generated an estimated $2.6M in annual revenue.

When was Altris AI founded?

Altris AI was founded in 2018.

How many employees does Altris AI have?

As of 2025, Altris AI had 24 employees.

Where is Altris AI headquartered?

Altris AI is headquartered in Chicago, Illinois, United States.

Compare Altris AI to the industry

Altris AI operates across multiple industries. Browse revenue, funding, and growth data for Altris AI in each sector below.

Data and Sources

All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.

Claim this profile